Table 7. Cumulative content of salidroside and p-tyrosol in biliary samples following i.v. and i.g. administration of salidroside (i.v. 50 mg/kg, i.g. 100 mg/kg) (n = 6).
Time (h) | i.v. administration (µg) | i.g. administration (µg) | ||
Salidroside | p-tyrosol | Salidroside | p-tyrosol | |
0–1 | 281.00±9.39 | 0.55±0.05 | 0.14±0.03 | 0.04±0.00 |
1–2 | 52.02±4.27 | 0.55±0.02 | 0.22±0.03 | 0.04±0.01 |
2–3 | 9.90±0.12 | 0.05±0.00 | 0.74±0.06 | 0.05±0.00 |
3–4 | 5.80±0.44 | 0.05±0.01 | 1.18±0.19 | 0.05±0.00 |
4–5 | 5.62±0.12 | 0.06±0.00 | 1.79±0.07 | 0.06±0.01 |
5–6 | 4.42±0.38 | 0.05±0.00 | 0.53±0.09 | 0.07±0.01 |
0–6 | 358.77±5.54 | 1.30±0.04 | 4.65±0.13 | 0.32±0.02 |
Excretion (% of dose) | 2.86±0.04 | 0.02±0.00 | 0.02±0.00 | 0.00±0.00 |